Upload
market-research-reports-inc
View
75
Download
1
Embed Size (px)
DESCRIPTION
As a result of Phase III therapy LMTX potentially entering the Alzheimer’s Disease (AD) industry in the near future, the AD market will increase slightly from $3.6 billion in 2012 to $3.8 billion in 2019. For more information visit: http://www.marketresearchreports.com/gbi-research/alzheimers-disease-therapeutics-market-2019-early-stage-innovation-points-disease
Citation preview
www.MarketResearchReports.com
Alzheimer's Disease
Therapeutics Market to 2019 -
Early Stage Innovation Points
to Disease Modifying
Therapies and Market
TransformationCategory : Diseases
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Introduction to Report
Launch Date: October 31, 2013
Number of Pages: 90
Geography Coverage: Global
Available Format: PDF
Price For Single User License: USD 3,500
Price For Site License: USD 7,000
Price For Global User License: USD 10,500
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com
About the Report
The Alzheimer's Disease (AD) market is characterized by a lack of products with strong disease-modifying properties and a number of high-profile product failures in late stages of development over recent years. In addition, recent or impending patent expiries for all of the four currently marketed products and a late-stage pipeline with limited-to-moderate prospects are expected to impede growth over the next few years.
The Alzheimer’s Disease market will increase slightly from $3.6 billion in 2012 to $3.8 billion in 2019.
www.MarketResearchReports.com
Scope
A brief introduction to AD etiology, pathogenesis, diagnosis, and treatment regimes
Profiling of the marketed products in the AD market, including analysis of their safety, efficacy, treatment patterns, and strengths and weaknesses
Comprehensive review of the pipeline for AD therapies, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market during the forecast period. The pipeline is analyzed on the basis of phase distribution, molecule type, and molecular target.
Additional in-depth analysis of pipeline drug clinical trials, analyzed by phase, molecule type, trial size, trial duration and program failure rate, for each molecule type and mechanism of action
Multi-scenario forecast data for the market to 2019, taking into account how it will be affected by the introduction of new drugs, the expiry of key patents on current drugs, and changes in disease epidemiology across the key developed markets of the US, Japan, Germany, the UK, France, Italy and Spain
www.MarketResearchReports.com
Reasons to Buy
Understand the different levels of AD therapies, from early-stage or mild AD to severe AD
Understand the vast scope of the pipeline, including which molecule types and mechanisms of action are prominent
Observe trends in terms of clinical trial duration and size among clinical phases and molecule types, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for AD therapeutics
Assess the potential clinical and commercial impact of current late-stage pipeline molecules on the AD therapeutics market
www.MarketResearchReports.com
Report Coverage
1. Marketed Products
2. Pipeline for Alzheimer's Disease Therapeutics
3. Market Forecast to 2019
4. Deals and Strategic Consolidations
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Custom Research: Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.
For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and purchase this publication:
http://www.marketresearchreports.com/gbi-research/alzheimers-disease-therapeutics-market-2019-early-stage-innovation-points-disease
About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.
Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)